The current status of interferon-α treatment in advanced renal cancer
Open Access
- 1 May 2001
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 87 (7) , 599-601
- https://doi.org/10.1046/j.1464-410x.2001.02140.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Immunotherapy for advanced renal cell cancerCochrane Database of Systematic Reviews, 2015
- Interaction of Retinoic Acid and Interferon in Renal Cancer Cell LinesJournal of Interferon & Cytokine Research, 2000
- Phase III Trial of Interferon Alfa-2a With or Without 13-cis-Retinoic Acid for Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2000
- Adjuvant interferon-alpha in malignant melanoma: current statusCancer Treatment Reviews, 2000
- Modest effect of interferon alfa on metastatic renal-cell carcinomaThe Lancet, 1999
- Interferon-α and survival in metastatic renal carcinoma: early results of a randomised controlled trialThe Lancet, 1999
- Kidney cancerThe Lancet, 1998
- Interferon‐alpha and survival in renal cell cancerBritish Journal of Urology, 1995
- Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinomaUrology, 1995
- The Impact of Interleukin-2 on Survival in Renal Cancer: A Multivariate AnalysisCancer Biotherapy, 1993